Fundraising FoxVerve Medical
Santa Barbara, US · Founded 2011 · 1 known investors
Find your way into Verve Medical
Sign up to see every warm intro you have to Verve Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Verve Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure. It targets patients with uncontrolled hypertension who do not respond well to medication.
Founders & leadership
Board
WW
Wayne WuBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2014–2016
▶$470KraisedJan 2017 · 5 investors · OtherRule 506(b)
▶$470KraisedJan 2017 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Terry BuelnaExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $470K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2015 · 1 investors · OtherRule 506(b)
▶$2MraisedOct 2015 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Terry BuelnaExecutive Officer, Director
- Wayne WuDirector
- Steve GexExecutive Officer, Director
- Offering amount
- $2.1M
- Amount sold
- $2M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Verve TherapeuticsCambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.
VeratxVera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
Companies working in the same space as Verve Medical.
Frequently asked questions
- What does Verve Medical do?
- Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure. It targets patients with uncontrolled hypertension who do not respond well to medication.
- Who are Verve Medical's investors?
- Verve Medical's investors include HM Venture Partners.
- How much funding has Verve Medical raised?
- Verve Medical has disclosed $2.4M raised across 2 rounds.
- Where is Verve Medical headquartered?
- Verve Medical is headquartered in Santa Barbara, US.